Clinical Trials Browser

Optic Nerve Glioma × pomalidomide × CNS × Clear all

NCT02415153 2022-04-25

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Phase 1 Completed

Neurofibromatosis 1, Central Nervous System Neoplasms, Optic Nerve Glioma